A Major Breakthrough In IVF Technology
A University of Adelaide reproductive biologist has achieved a major breakthrough in IVF technology that is expected to help millions of women around the world who have suffered previous miscarriages after IVF treatment.
Professor Sarah Robertson, an NHMRC Principal Research Fellow and member of the University’s Robinson Institute, has partnered with a Danish company to develop a product which improves IVF embryo implantation rates for some women by up to 40%.
In the world’s largest clinical trial on IVF media, Professor Robertson and ORIGIO a/s – a European company specialising in assisted reproductive technologies – have shown for the first time that growth factor molecules are critical to ensuring optimal embryo development.
The resulting product, EmbryoGen, to be released in 2011, contains a signalling molecule called GM-CSF found naturally in the mother’s tissues which protects the embryo from stress, making it stronger and more robust in the early implantation period.
www.jihsin.com
- The central office of IRTSA Ukraine completely restores work
- How we work during the COVID-19 pandemic
- 1st International Congress on Reproductive Law
- Soon Americans may face a new ethical dilemma
- ‘Friends’ star Jennifer Aniston is pregnant with twins
- Image processing technology can impact the success rates of ivf
- Editing genes of human embryos can became the next big thing in genetics
- Supermodel Tyra Banks undergoes IVF
- Scientists discovered a new, safer way for egg freezing
- French scientists have managed to grow human sperm cells in vitro








